Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 tags : Events save search
Keros Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Exposition, Including Presenting Additional Data from its Phase 2 Clinical Trial Evaluating KER-050 in Patients with Myelodysplastic Syndromes
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
KROS | $58.345 -1.03% -1.04% 350K
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
ema phase 2 trial syndros
Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
ARMP | $2.61 2.35% 2.11% 9.6K
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
Centene To Present At Credit Suisse 30th Annual Healthcare Conference
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
CNC | $75.15 1.9% 0.0% 2.7M
|
Health Services
|
| O: 0.77%
H: 0.0%
C: 0.0%
conference
Imago BioSciences Announces Oral Data Presentations at the Upcoming 63rd American Society of Hematology Annual Meeting and Exposition
Published: 2021-11-04 (Crawled : 22:00) - biospace.com/
IMGO | $36.01 0.03% 0.0% 0
|
Health Technology
|
| O: 0.32%
H: 6.09%
C: -0.49%
presentation ema
MorphoSys Presents Interim Results from M-PLACE Study with Felzartamab during American Society of Nephrology Annual Meeting
Published: 2021-11-04 (Crawled : 22:00) - biospace.com/
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -1.33%
H: 0.58%
C: -0.08%
IMAB | $1.81 0.56% 0.55% 340K
|
Health Technology
|
| O: 0.56%
H: 2.78%
C: -0.81%
results
Apellis to Present New Data Reinforcing EMPAVELI™ (pegcetacoplan) Efficacy and Safety in Patients with PNH at the 2021 ASH Annual Meeting
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
APLS G | $47.53 0.04% 0.04% 1.2M
|
Health Technology
|
| O: 0.0%
H: 3.19%
C: -0.15%
Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition
Published: 2021-11-04 (Crawled : 21:00) - biospace.com/
GRPH 4 | $3.27 1.84% 490K
|
Professional, Scientific, and T...
|
| O: 0.38%
H: 2.12%
C: -3.71%
presentation disease phase 1 trial
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2021
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: 1.07%
H: 1.2%
C: -0.27%
financial results results
DiaMedica Therapeutics to Report Third Quarter 2021 Financial Results and Provide a Business Update November 11, 2021
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
DMAC | $2.46 -1.21% -1.22% 21K
|
Health Technology
|
| O: 0.0%
H: 1.14%
C: -1.6%
financial results results
Legend Biotech Showcases Updated and New Data from Comprehensive BCMA CAR-T, Cilta-Cel, Program and First Preclinical Results for Tri-specific CAR-T at 2021 ASH
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -1.14%
H: 1.45%
C: -4.71%
car-t results biotech iot preclinical cel pre-clinical
Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC 2021 Meeting
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: -2.2%
Relmada Therapeutics to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
RLMD | $4.0 -6.98% -7.5% 150K
|
Health Technology
|
| O: 0.2%
H: 0.59%
C: -0.28%
financial results results conference
MD&M East Announces 2021 Keynote and Speaker Lineup Set to Deliver Technical and Forward-looking Insights Impacting Medical Device Manufacturers
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
device liver
VectivBio to Present at the Credit Suisse 30th Annual Healthcare Conference
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -4.12%
H: 13.96%
C: 5.74%
conference
OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number of Authorized Shares of Common Stock
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 0.56%
H: 0.0%
C: 0.0%
authorized
Atea Pharmaceuticals to Host Third Quarter Financial Results Conference Call on November 11, 2021
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
AVIR | $3.7 0.0% 220K
|
Health Technology
|
| O: 4.74%
H: 0.58%
C: -3.13%
financial results results conference
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.